These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 7511983

  • 1. Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possibly via P-glycoprotein.
    Gupta S, Patel K, Singh H, Gollapudi S.
    Cancer Lett; 1994 Jan 30; 76(2-3):139-45. PubMed ID: 7511983
    [Abstract] [Full Text] [Related]

  • 2. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells.
    Gollapudi S, Kim CH, Tran BN, Sangha S, Gupta S.
    Cancer Chemother Pharmacol; 1997 Jan 30; 40(2):150-8. PubMed ID: 9182837
    [Abstract] [Full Text] [Related]

  • 3. Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy.
    Gervasoni JE, Fields SZ, Krishna S, Baker MA, Rosado M, Thuraisamy K, Hindenburg AA, Taub RN.
    Cancer Res; 1991 Sep 15; 51(18):4955-63. PubMed ID: 1680024
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S, Pierré A, Anstett M, Pérez V, Genton A, Bizzari JP, Atassi G.
    Biochem Pharmacol; 1992 Nov 03; 44(9):1707-15. PubMed ID: 1360210
    [Abstract] [Full Text] [Related]

  • 9. Transport mechanisms of anthracycline derivatives in human leukemia cell lines: uptake of pirarubicin, daunorubicin and doxorubicin by K562 and multidrug-resistant K562/ADM cells.
    Nagasawa K, Takara K, Nomiyama M, Ohnishi N, Yokoyama T.
    Biol Pharm Bull; 1996 Jul 03; 19(7):971-6. PubMed ID: 8839972
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
    Ross DD, Doyle LA, Yang W, Tong Y, Cornblatt B.
    Biochem Pharmacol; 1995 Nov 09; 50(10):1673-83. PubMed ID: 7503771
    [Abstract] [Full Text] [Related]

  • 12. Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists.
    Kessel D, Wilberding C.
    Cancer Res; 1985 Apr 09; 45(4):1687-91. PubMed ID: 3919944
    [Abstract] [Full Text] [Related]

  • 13. Exploring multidrug resistance using rhodamine 123.
    Kessel D.
    Cancer Commun; 1989 Apr 09; 1(3):145-9. PubMed ID: 2639727
    [Abstract] [Full Text] [Related]

  • 14. Induction of resistance to daunorubicin in drug-sensitive leukemia p388 cells - a role of pkc-Beta-I isozyme.
    Gollapudi S, Deniega J, Soni V, Gupta S.
    Int J Oncol; 1994 Dec 09; 5(6):1227-31. PubMed ID: 21559702
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Circumvention of daunorubicin resistance by a new tamoxifen derivative, toremifene, in multidrug-resistant cell line.
    Urasaki Y, Ueda T, Nakamura T.
    Jpn J Cancer Res; 1994 Jun 09; 85(6):659-64. PubMed ID: 7914886
    [Abstract] [Full Text] [Related]

  • 19. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
    Dietel M, Herzig I, Reymann A, Brandt I, Schaefer B, Bunge A, Heidebrecht HJ, Seidel A.
    J Cancer Res Clin Oncol; 1994 Jun 09; 120(5):263-71. PubMed ID: 7907333
    [Abstract] [Full Text] [Related]

  • 20. Effects of protein kinase C modulators on multidrug resistance in human glioma cells.
    Matsumoto T, Tani E, Yamaura I, Miyaji K, Kaba K.
    Neurosurgery; 1995 Mar 09; 36(3):565-71; discussion 572. PubMed ID: 7538636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.